Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The NOTION study investigates in-home sampling of cytokines in cancer patients receiving immunotherapy, and the trial has completed. The con…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies [Phase 1, Phase 2]
Phase 1/2 trial of plinabulin with radiation and immunotherapy in select advanced cancers after progression on PD-1/PD-L1 therapy was termin…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors [Phase 1]
Phase 1 study of PF-08046031 in advanced melanoma and other solid tumors was terminated. The trial status is TERMINATED.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating a gene-modified immune cell therapy after a conditioning regimen for metastatic melanoma and other metas…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors [Phase 2]
Phase 2 trial of brentuximab vedotin in combination with pembrolizumab for metastatic solid tumors has completed, enrolling patients with me…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: AI-based Medical Device Validation for Early Melanoma Detection
Completed validation study of an AI-based medical device for early melanoma detection; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response [NA]
A terminated clinical trial (NCT02439008) investigating early biomarkers of tumor response to high-dose hypofractionated radiotherapy across…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma [Phase 1]
Phase 1 trial evaluating the safety and tolerability of an intravenously administered cancer vaccine in patients with advanced melanoma has …
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma [Phase 2]
Phase 2 clinical trial evaluating metronomic cyclophosphamide with pembrolizumab for checkpoint inhibitor-refractory melanoma; study is curr…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases [Phase 1]
This phase 1 study assessed pembrolizumab in combination with stereotactic radiosurgery for patients with brain metastases from melanoma or …
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma [Phase 2]
A Phase 2 trial comparing three-study medicines (encorafenib, binimetinib, pembrolizumab) to two-study medicines (ipilimumab and nivolumab) …
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India [Phase 4]
ClinicalTrials.gov update for a Phase 4 study evaluating the safety and tolerability of a fixed-dose combination of nivolumab and relatlimab…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) [Phase 2]
Phase 2 basket study evaluating entrectinib in solid tumors harboring NTRK1/2/3, ROS1, or ALK gene rearrangements; the study is listed as Ac…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer [Phase 2]
Phase 2 trial evaluating psilocybin-assisted existential therapy (PEARL) for patients with advanced cancers; the study is currently active b…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway [Phase 1]
Phase 1 trial of DCC-3084 for MAPK-pathway driven advanced cancers has been terminated. The update notes the study status without presenting…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma [NA]
Clinical trial investigating IFN-gamma expression as a predictor of response to immune checkpoint inhibitors in first-line metastatic melano…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma [Phase 1]
Phase 1 trial update for XL888 in combination with Vemurafenib and Cobimetinib in unresectable, BRAF-mutated stage III/IV melanoma; the stud…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating molecular profiling-guided matched targeted therapy in patients with unresectable advanced or metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma [Phase 1]
This Phase 1 trial studied the combination of trametinib and ceritinib in patients with unresectable or advanced melanoma and has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry [NA]
A clinical trial evaluating measurement of tissue oxygen in cutaneous tumors (skin cancer and melanoma) using electron paramagnetic resonanc…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma [Phase 2]
A Phase 2 trial evaluating a polarized dendritic cell (aDC1)-based treatment in combination with Interferon Alpha-2, Rintatolimod, and Celec…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Lavender Aromatherapy for Preoperative Anxiety in Melanoma and Epithelioma Patients [NA]
A completed trial evaluated lavender aromatherapy for reducing preoperative anxiety in patients with melanoma or non-melanoma skin cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers
A completed clinical trial evaluating an AI medical device to help primary care practitioners identify and manage skin conditions in adults …
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
The clinical trial evaluating an AI diagnostic tool for primary care doctors assessing skin conditions has been completed. The study evaluat…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Circulating Tumor DNA in Melanoma Patients [NA]
Completed clinical trial investigating circulating tumor DNA in melanoma patients; the update summarizes the trial status and findings.